NEOS ETF Trust Kurv Yield Premium Strategy Tesla (TSLA) ETF (BATS: TSLP)

Latest news for NEOS ETF Trust Kurv Yield Premium Strategy Tesla (TSLA) ETF (BATS:TSLP)

The Fund is an actively managed exchange traded fund that seeks current income while maintaining the opportunity for exposure to the share price i.e., the price returns of the common stock of Tesla Inc. (TSLA); however the strategy limits potential investment gains related to share price appreciation. The Fund seeks to employ its investment strategy as it relates to TSLA in all market, economic, or other conditions. The Fund uses a synthetic covered call strategy to provide (1) income derived from options premiums and (2) exposure to the share price returns of TSLA, subject to a limit on potential share price returns on TSLA as a result of the nature of the options strategy it employs.

Kurv Yield Premium Strategy Tesla (TSLA) ETF

NEOS ETF Trust Kurv Yield Premium Strategy Tesla (TSLA) ETF

Goldman Sachs analyst James Schneider maintains Cognizant Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSH#NASDAQ">CTSH</a>) with a Neutral and raises the price target from $75 to $76.

News

Price Target

Analyst Ratings

CTSH

Goldman Sachs Maintains Neutral on Cognizant Tech Solns, Raises Price Target to $76

DA Davidson analyst Brian Holland maintains Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>) with a Neutral and maintains $8 price target.

HAIN

DA Davidson Maintains Neutral on Hain Celestial Group, Maintains $8 Price Target

Wednesday, Neurocrine Biosciences, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) topline data for its Phase 2 clinical study of NBI-1117568 (NBI-&#8216;568) in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/n40596900/neurocrine-biosciences-reports-positive-phase-2-data-for-nbi-1117568-in-adults-with-schizophrenia" rel="noreferrer noopener">adults with schizophrenia</a>.
NBI-&#8216;568 is the first investigational, oral, muscarinic M4 <a target="_blank" href="https://www.benzinga.com/quote/nbix" rel="noreferrer noopener">selective agonist</a>.
The new data showed that the once-daily 20 mg dose of NBI-&#8216;568 induced an average 18.2-point reduction from baseline in the Positive and Negative Syndrome Scale (PANSS) after six weeks, compared to 10.8 points in the placebo group.
Also Read: <a target="_blank" href="https://www.benzinga.com/m-a/24/08/40586451/regulators-expected-to-approve-innovative-schizophrenia-treatment-from-bristol-myers-karuna" rel="noreferrer noopener">Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna</a>.
That 7.5-point difference reached statistical significance with a p-value of p=0.011.
The company noted that none of the other three higher-dosing groups (30, 40, and 60 mg) reached statistical significance.
William Blair notes that while this effect size is in line with what was demonstrated by Bristol Myers Squibb&nbsp;Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)&nbsp;acquired Karuna&#8217;s KarXT, the 7.5 delta versus placebo is lower than the 11.6 difference in the Phase 3 EMERGENT-2 study.
It was also lower than the 0.75 effect size and 11.6-point delta from placebo from the EMERGENT-1 Phase 2 study and the 12.7-point and 11.1-point improvement over placebo with AbbVie Inc&#8217;s (formerly Cerevel&#8217;s) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) emraclidine.
&#8220;We do highlight that the placebo improvement of 10.8 points is greater than what was seen in prior Phase II studies of KarXT and emraclidine, which is unsurprising given potential expectation bias around a more well-validated mechanism and is more in line with prior studies of antipsychotics historically,&#8221; William Blair analyst adds.
Price Action: NBIX stock is down 18.90% at $123.71&nbsp;at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/08/40601410/novartis-cholesterol-lowering-drug-shows-encouraging-outcome-in-late-stage-study" target="_blank" rel="noreferrer noopener">Novartis&#8217; Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study</a>.</li>
</ul>

Biotech

Health Care

Movers

Trading Ideas

General

ABBV

NBIX

As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors

UTime Shares Resumes Trade

On March 15, 2024, <a href="https://www.globenewswire.com/Tracker?data=7dCbAdADlc23h8lO5d5cpuF4aRBALmaMXypHbFz_LVgPDWRrTx5o1DY-ksX2QqmVpdgTy0KXYNcM9Q-03KT3iA==">Telos Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>), announced that it had teaming agreements in place with prime partners who received awards from the federal government worth up to $525 million to Telos' Security Solutions business over five years. Telos also announced that the awards had been protested pursuant to a customary post-award protest period provided by the federal government and that finalization of the awards was subject to the resolution of protests.
On August 28, 2024, the Government Accountability Office ("GAO") publicly disclosed that the protester on an award worth up to $485 million to Telos over five years had withdrawn its protest. Telos' prime partner has advised Telos that the government's "Stop-Work Order" on this same award has been formally lifted, effective September 28, 2024.
One other award worth up to $40 million to Telos over five years remains under protest.

Contracts

Legal

Telos Resolves Protest With Federal Government On An Award Worth Up To $485M Over 5-Years

Former President Donald Trump is about to face a major decision that could shake up the financial world and his fortune. By the end of September, Trump will be free to sell his entire stake in <a href="https://www.benzinga.com/topic/trump-media-technology-group">Trump Media &amp; Technology Group</a>, which owns his social media platform, Truth Social. But what happens if he decides to cash out?
Don't Miss:
<ul>
<li>Don&#8217;t miss the real AI boom &#8211;<a href="https://www.benzinga.com/money/fundrise-innovation-fund"> here&#8217;s how to use just $10 to invest in high growth private tech companies.</a></li>
<li>Amid the ongoing EV revolution, previously overlooked low-income communities<a href="https://www.benzinga.com/money/dunamis-1"> now harbor a huge investment opportunity at just $500.</a></li>
</ul>
<a href="https://www.benzinga.com/general/politics/24/06/39417590/trump-could-cash-out-3-2b-stake-in-namesake-media-company-and-still-maintain-voting-control">Trump currently owns more than 114 million shares</a> in Trump Media, a stake valued at about $2.5 billion. That's a big chunk of his estimated $4.3 billion net worth. Until now, he hasn't been able to sell these shares because of a lockup agreement – a rule that prevents company insiders from selling their stock right after the company goes public. But that restriction is set to end in late September.
See Also: Don&#8217;t miss out on the next Nvidia &#8211;<a href="https://www.benzinga.com/money/fundrise-innovation-fund"> you can invest in the future of AI for only $10.</a>
If Trump decides to sell, it could have major consequences. For one, the stock price might plummet. Financial experts are already worried that if Trump dumps his shares, there might not be enough buyers willing to snap them up, which could cause the stock to drop even more.&nbsp;
As Steve Sosnick, Chief Strategist at <a href="https://www.benzinga.com/money/interactive-brokers-review">Interactive Brokers</a>, pointed out, the overall stock market has been doing well, but Trump Media&#8217;s stock <a href="https://www.benzinga.com/government/24/08/40464675/whats-going-on-with-trump-media-tech-stock-on-tuesday">has been trending downward.</a> It closed at $21.42 recently, its lowest since going public. "The rising tide hasn't lifted that boat," he said.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: With over 15k units already sold, this female-owned dog waste startup is targeting the $147 billion pet industry –<a href="https://www.benzinga.com/money/goodwag"> here&#8217;s how to invest early at just $1 per share</a>.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Why is this happening? Trump Media's fortunes are closely tied to Trump's reputation and popularity. As the 2024 election heats up, Trump's standing in the polls <a href="https://www.benzinga.com/news/24/08/40541978/trump-vs-harris-kamala-harris-takes-8-point-lead-in-new-poll-with-race-and-gender-shaping-voter-pref">has taken a hit after Kamala Harris</a> took the lead as the Democratic nominee.&nbsp;
<a href="https://www.benzinga.com/topic/matthew-tuttle">Matthew Tuttle</a>, CEO of Tuttle Capital Management, didn't mince words, telling Politico that Trump has &#8220;stepped on just about every rake he possibly could&#8221; since his acceptance speech at the Republican National Convention. This has been &#8220;hammering the stock.&#8221;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Groundbreaking trading app with a ‘Buy-Now-Pay-Later' feature for stocks tackles the $644 billion margin lending market –<a href="https://www.benzinga.com/money/wolfpack"> here&#8217;s how to get equity in it with just $100</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
According to its latest earnings report, the company is having a tough time financially, losing over $16 million in just three months. It&#8217;s clear to almost everyone that Trump Media&#8217;s future depends on the 2024 election. If Trump wins the election, that alone could boost the company's stock and do a complete 180.
Investors are worried that Trump might sell his shares to cover his growing legal bills or fund his campaign. But selling such a large stake could flood the market with too many shares, pushing the price down further. And with Truth Social not generating much revenue compared to bigger platforms like X (formerly Twitter) and Facebook, Trump Media's sky-high valuation doesn't match its actual financial performance.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trump hasn't said what he plans to do once he's free to sell his shares, and his team isn't giving any hints. Meanwhile, Trump Media is trying to expand its business, recently adding in-app streaming to Truth Social. The company says it has $344 million in cash and no debt, which gives it some breathing room.
For now, all eyes are on Trump as he prepares to make a decision that could affect not just his fortune but also the future of his media empire and the investors who have big bets on him.
Read Next:
<ul>
<li>A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a></li>
<li><a href="https://www.benzinga.com/money/fundrise-innovation-fund">When today&#8217;s AI startups go public, most of the rapid growth will be behind them — here&#8217;s how not to get left out.</a></li>
</ul>

Startups

Trump Soon Free To Sell All His Stake In Trump Media. Here's What Happens If He Does – 'He's Stepped On Just About Every Rake'

DA Davidson analyst Linda Bolton Weiser maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Buy and maintains $130 price target.

DA Davidson Maintains Buy on Estee Lauder Cos, Maintains $130 Price Target

DA Davidson analyst Linda Bolton Weiser maintains Prestige Consumer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBH#NYSE">PBH</a>) with a Buy and raises the price target from $93 to $95.

DA Davidson Maintains Buy on Prestige Consumer, Raises Price Target to $95

Conglomerate Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) became the 10th public company to surpass the $1 trillion market capitalization milestone on Wednesday, further reshaping the dynamic leaderboard of the<a href="https://www.benzinga.com/news/24/06/39386946/microsoft-apple-step-aside-nvidia-is-now-the-most-valuable-public-company-in-the-world"> most valuable company in the world.</a>
What Happened: Under the <a href="https://www.benzinga.com/general/movers-shakers/21/08/17298128/warren-buffett-turns-91-a-highlight-for-each-decade-of-his-life-1">long-time leadership</a> of Warren Buffett, Berkshire Hathaway has reached the $1 trillion mark, with shares up 28% year-to-date in 2024.
The stock is one of eight companies to currently be valued at $1 trillion or more. Berkshire Hathaway is also the first U.S. based non-technology company to pass the milestone.
The current list of $1 trillion valued public companies is:
<ul>
<li>Apple: $3.47 trillion</li>
<li>Nvidia: $3.12 trillion</li>
<li>Microsoft: $3.06 trillion</li>
<li>Alphabet: $2.02 trillion</li>
<li>Amazon.com: $1.80 trillion</li>
<li>Saudi Aramco: $1.79 trillion</li>
<li>Meta Platforms: $1.30 trillion</li>
<li>Berkshire Hathaway: $1.03 trillion</li>
</ul>
Previous members of the club include Petro China and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
"As Berkshire Hathaway approaches a $1 trillion market cap, which company will be the next to reach this milestone?" Benzinga asked earlier this week.
Here are the results and the market capitalizations at the time of the poll:
<ul>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>): 43%</li>
<li>Taiwan Semiconductor Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>): 25%</li>
<li>Tesla: 19%</li>
<li>Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>): 11%</li>
<li>Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>): 3%</li>
</ul>
At the time of writing, Taiwan Semiconductor and Eli Lilly are closest to hitting the milestone, with both companies worth over $800 billion. Eli Lilly won the poll with a near majority of the five selections. Taiwan Semiconductor Manufacturing ranked second with a quarter of the vote.
Broadcom, which has the next highest market capitalization at $743 billion, ranked fourth. Tesla ranked third, despite having a lower market capitalization of $665 billion. Walmart, which has a market capitalization of $610 billion, finished fifth in the poll.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent082824">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: While it seems like Nvidia has been one of the most valuable companies in the world for some time, the company passed the $1 trillion market cap milestone just 15 months ago,<a href="https://www.benzinga.com/news/23/05/32630114/nvidia-becomes-ninth-company-to-hit-1-trillion-market-cap-who-could-be-next-to-join-elusive-club"> back in May 2023,</a> and briefly became the most valuable company in the world<a href="https://www.benzinga.com/news/24/06/39386946/microsoft-apple-step-aside-nvidia-is-now-the-most-valuable-public-company-in-the-world"> earlier this year.</a>
Meta Platforms, which was a past member of the $1 trillion market capitalization before falling out, re-joined the club earlier this year.
Last May, when Nvidia joined the club, Benzinga asked its social media followers which stock would be next to join or re-join the $1 trillion market capitalization club.
Tesla was <a href="https://www.benzinga.com/news/23/06/32698111/nvidia-recently-hit-a-1-trillion-market-cap-which-stock-is-next-to-join-club-heres-what-benzinga-use">the overwhelming favorite </a>on X at 53.8% of the vote. Ranking second was Taiwan Semiconductor. While neither of those companies has hit the $1 trillion market cap level since then, the third and fourth place finishers in Meta at 15% and Berkshire at 12.9% are now both members.
This just goes to show that the market can be unpredictable.
Berkshire Hathaway has posted impressive gains over the years under Buffett's leadership, and the company&#8217;s ownership of key brands alongside a stock portfolio that includes Apple and other blue chip stocks.
That could be why it's no surprise that Benzinga readers recently selected Buffett as the person <a href="https://www.benzinga.com/top-stories/24/08/40423891/buffett-musk-wood-cuban-or-ackman-who-do-investors-trust-most-with-life-savings-poll-shows-it-isnt-e">they would trust </a>most with investing their life savings in a poll. Buffett was selected with an overwhelming 58% of the vote over the likes of Ray Dalio, Cathie Wood, Elon Musk, Bill Ackman, Mark Cuban and Jamie Dimon.
Berkshire Hathaway shares are up 31% in the past year and up 129% over the last five years.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/08/40531771/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
The study was conducted by Benzinga on Aug. 26 through Aug. 27, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 101 adults.
Image created using artificial intelligence via Midjourney.

Exclusives

AVGO

TSLA

Warren Buffett's Berkshire Hathaway Breaks $1 Trillion: Poll Points To Big Pharma, Not Tech, As Next Contender

DA Davidson analyst Michael Baker maintains Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) with a Buy and lowers the price target from $33 to $20.

CTRN

DA Davidson Maintains Buy on Citi Trends, Lowers Price Target to $20

UTime Shares Halted On Circuit Breaker To The Downside, Stock Now Down -83%

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains First Merchants (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRME#NASDAQ">FRME</a>) with a Outperform and maintains $45 price target.

FRME

Keefe, Bruyette & Woods Maintains Outperform on First Merchants, Maintains $45 Price Target

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains CrossFirst Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFB#NASDAQ">CFB</a>) with a Outperform and maintains $20 price target.

Keefe, Bruyette & Woods Maintains Outperform on CrossFirst Bankshares, Maintains $20 Price Target

Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is set to report its highly anticipated earnings on Aug. 28, and the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40597015/will-nvidia-continue-to-deliver-investors-sweat-over-hyped-up-expectations-and-pote">stakes couldn't be higher.</a>
As the undisputed leader in the AI revolution, Nvidia&#8217;s results will be a critical indicator for the broader market, particularly for those invested in semiconductor and technology sectors.
This highly followed market event offers both risk and opportunity. For traders seeking to capitalize on Nvidia's earnings without the direct exposure to single-stock volatility, ETFs with substantial Nvidia holdings present an appealing alternative. 
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40596306/market-eyes-305b-shift-in-nvidias-market-cap-as-options-pricing-forecasts-9-8-post-">Market Eyes $305B Shift In Nvidia&#8217;s Market Cap As Options Pricing Forecasts 9.8% Post-Earnings Move: &#8216;A Lot Of That Insurance Is FOMO&#8217;</a>
<h3 class="wp-block-heading">Nvidia Earnings Expectations: A High Bar Set</h3>
Wall Street has set an ambitious target for Nvidia this quarter, with revenue expected to hit $28.74 billion — a staggering 17% increase from the previous quarter and an eye-popping 156% jump from the same quarter last year. 
Earnings per share (EPS) are forecasted to rise to 65 cents, up from 56 cents in the prior quarter and 21 cents in the same period last year.
Goldman Sachs&#8217; semiconductor analyst, Toshiya Hari, is bullish on Nvidia&#8217;s prospects, predicting the company will surpass these already lofty expectations. 
&#8220;We believe customer demand across the large Cloud Service Providers and enterprises is strong, and Nvidia&#8217;s robust competitive position in AI/accelerated computing remains intact,&#8221; Hari stated in a note published this month. 
The driving force behind this optimism? Data Center revenues and strong operating leverage. Hari highlights three key areas: robust demand for the H100 GPUs, the launch of volume shipments of the H200, and the ramp-up of Nvidia&#8217;s Ethernet-based networking product, Spectrum-X. These factors could fuel a significant earnings beat, potentially leading to upward revisions in EPS.
Shares of the AI tech giant are up 159% year to date, after surging by 239% in 2023. 
<h3 class="wp-block-heading">Historical Volatility: A Look At Past Nvidia Earnings</h3>
Nvidia&#8217;s stock has a history of sharp rallies post-earnings, with an average one-day boost of 9% over the past eight quarters and 7.1% over the last four.
A Goldman Sachs analysis identified the VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>) as having the highest average post-earnings move (3.4%) following Nvidia's past eight earnings releases. 
It was followed by the iShares Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NYSE">SOXX</a>) at 2.9% and the ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>) at 2.4%.
<h3 class="wp-block-heading">Top 10 ETFs With Nvidia Exposure</h3>
For traders looking to gain exposure to Nvidia's potential earnings-driven rally, here are 10 ETFs with the largest holdings in the stock:
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>ETF Name</th>
<th>Nvidia Weight %</th>
<th>YTD Performance (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>ProShares Ultra Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USD#NYSE">USD</a>)</td>
<td>30.69%</td>
<td>136%</td>
</tr>
<tr>
<td>Strive U.S. Semiconductor ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NYSE">SHOC</a>)</td>
<td>29.54%</td>
<td>19.2%</td>
</tr>
<tr>
<td>Simplify Volt RoboCar Disruption (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VCAR#NYSE">VCAR</a>)</td>
<td>22.83%</td>
<td>12.7%</td>
</tr>
<tr>
<td>VanEck Semiconductor ETF </td>
<td>21.95%</td>
<td>41.3%</td>
</tr>
<tr>
<td>The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>21.29%</td>
<td>16.7%</td>
</tr>
<tr>
<td>Grizzle Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DARP#NYSE">DARP</a>)</td>
<td>20.32%</td>
<td>13.9%</td>
</tr>
<tr>
<td>Franklin Focused Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFOG#NYSE">FFOG</a>)</td>
<td>18.07%</td>
<td>26.4%</td>
</tr>
<tr>
<td>iShares Global Tech ETF (IXN)</td>
<td>17.55%</td>
<td>21.6%</td>
</tr>
<tr>
<td>iShares ESG Advanced MSCI USA ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USXF#NYSE">USXF</a>)</td>
<td>16.05%</td>
<td>22.4%</td>
</tr>
<tr>
<td>SoFi Select 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFY#NYSE">SFY</a>)</td>
<td>15.96%</td>
<td>20.5%</td>
</tr>
</tbody>
</table>
</figure>
Now Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40600345/big-tech-is-your-flight-to-safety-and-your-flight-to-growth-says-expert-ahead-of-nv">&#8216;Big Tech Is Your Flight To Safety And Your Flight To Growth,&#8217; Says Expert Ahead Of Nvidia Earnings</a></li>
</ul>

Equities

Large Cap

Sector ETFs

Broad U.S. Equity ETFs

Tech

ETFs

ARKK

DARP

Franklin Templeton ETF Trust Franklin Focused Growth ETF

FFOG

NVDA

EA Series Trust Strive U.S. Semiconductor ETF

SHOC

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

USXF

Simplify Volt RoboCar Disruption and Tech ETF

VCAR

10 ETFs Poised For Wild Swings Following Nvidia Earnings

Polestar Automotive Holding UK PLC&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNY#NASDAQ">PSNY</a>) shares are trading lower on Wednesday. The Swedish electric performance car brand disclosed that Michael Lohscheller will become <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40593214/polestar-announces-leadership-change-michael-lohscheller-appointed-ceo" rel="noreferrer noopener">CEO effective October 1, 2024</a>.
Lohscheller will succeed Thomas Ingenlath, who is stepping down after successfully positioning the brand for its next phase.
Michael Lohscheller has formerly worked as the CEO of Opel, VinFast, and Nikola. Polestar aims to expand its global presence and strengthen its position in the premium electric vehicle market.
Winfried Vahland, Polestar&#8217;s incoming Chairman, said, &#8220;Polestar has experienced an exceptional start-up phase and with a broader model line-up, Michael Lohscheller is the ideal leader to guide Polestar into its next chapter.&#8221;
&#8220;His deep industry knowledge, especially in driving operational excellence, developing a coherent product strategy and strengthening the global market presence will be instrumental in the next chapter of Polestar&#8217;s growth.&#8221;
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, PSNY stock has lost over&nbsp;70%&nbsp;in the last 12 months year. Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Kensho Smart Mobility ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAIL#NYSE">HAIL</a>).
Price Action: PSNY shares are down 14.6% at $0.9651 at the last check Wednesday.
Photo by Jeppe Gustafsson on Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40387487/polestar-starts-production-in-us-to-avoid-high-tariffs-imposed-on-china-made-evs" target="_blank" rel="noreferrer noopener">Polestar Starts Production In US To Avoid High Tariffs Imposed On China-Made EVs</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Don&#8217;t miss the opportunity to dominate in a volatile market at the&nbsp;<a target="_blank" href="https://www.benzinga.com/events/small-cap/global-small-cap-conference-2024/" rel="noreferrer noopener">Benzinga SmallCAP Conference</a>&nbsp;on Oct. 9-10 at the Chicago Marriott Downtown Magnificent Mile. Get exclusive access to CEO presentations, 1:1 meetings with investors, and valuable insights from top financial experts. Whether you&#8217;re a trader, entrepreneur, or investor, this event offers unparalleled opportunities to grow your portfolio and network with industry leaders. Secure your spot and get your tickets today!

Small Cap

Management

HAIL

PSNY

Why Is Polestar Automotive Stock Diving Today?

Greenway Greenhouse Cannabis Corporation (CSE:<a class="ticker" href="https://www.benzinga.com/stock/GWAY#CSE">GWAY</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/GWAYF#OTCQB">GWAYF</a>), a Canadian cannabis cultivator reported its interim financial statements on Wednesday for the first quarter ended June 30, 2024.
The Ontario-based company said it has achieved its highest net revenue and adjusted EBITDA results to date. The company also achieved positive net cash flow provided by operating activities, and the highest amount of cannabis sold in a quarter to date.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/28101244/ccc-oct-24-banner__1_-22.gif" alt="" class="wp-image-518554" /></a></figure>
"This performance reflects our focus and commitment to producing quality cannabis, and finding the best partners and pathways to bring it to consumers,&#8221; said CEO Jamie D&#8217;Alimonte. &#8220;We achieved this while still keeping our cost of production low, and our yields high. This combination is what we believe separates us from other public cannabis companies in Canada.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/07/40047803/greenways-full-year-net-loss-widens-sees-rebound-in-q4-as-revenue-increases-9-yoy">Greenway&#8217;s Full-Year Net Loss Widens, Sees Rebound In Q4 As Revenue Increases 9% YoY</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Q1 2024 Financial Highlights</h3>
<ul>
<li>Net revenue totaled CA$2.4 million ($1.8 million) in the quarter, compared to CA$1.8 million in the prior year's period, representing a 104% year-over-year increase.</li>
<li>Cost of sales comprised of CA$1.5 million of cash expenses and CA$483,800 of amortization expense resulting in a total gross margin before inventory impairment and fair value adjustments of 14%.</li>
<li>Gross profit totaled CA$342,922, compared to CA$260,884 in the prior year's period.</li>
<li>Operating loss amounted to CA$272,429, representing an improvement from an operating loss of CA$929,796 in the first quarter of last year.</li>
<li>Loss and comprehensive loss totaled CA$541,478, an improvement from CA$1.1 million loss in the prior year's period.</li>
<li>Adjusted EBITDA&nbsp;came in positive at&nbsp;CA$316,431, compared to CA$16,408 in the first quarter of fiscal 2013.</li>
</ul>
&#8220;This is the first full quarter that includes sales of our branded products, and I&#8217;m pleased to share that our MillRite pre-rolls ranked as the second highest-selling in Ontario within their size category,&#8221; D&#8217;Alimonte added. &#8220;Additionally, we recently completed our first harvest intended for international markets, the next step in distributing Greenway cannabis globally.&#8221;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/23/10/35222387/canadian-cannabis-cultivator-ramps-up-distribution-channels-via-new-partnership">Canadian Cannabis Cultivator Ramps Up Distribution Channels Via New Partnership</a></li>
</ul>

Cannabis

Earnings

CSE:GWAY

GWAYF

Greenway Cannabis Co. Doubles Q1 Net Revenue YoY, Highest Adjusted EBITDA Results To Date

<ul>
<li>Nvidia is poised for a dramatic shift in market value, with a potential swing of $300 billion in its market cap.</li>
<li>Nvidia&#39;s current valuation is approximately $3.14 trillion.</li>
<li>Bullish signs in Nvidia&#39;s stock suggest a possible move towards $150.</li>
</ul>
As NVIDIA Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) prepares for its upcoming earnings report, the tech giant stands on the brink of a potentially historic change in its market value. Industry analysts, using options pricing data, predict a possible swing of up to $300 billion in Nvidia&#39;s market capitalization.
This figure not only reflects the company&#39;s large valuation, around $3.14 trillion but also highlights the significant impact such a change could have, overshadowing the market caps of most S&amp;P 500 companies.
The stakes are especially high now. Market sensitivities are elevated, with options traders anticipating a 9.8% stock price fluctuation after the earnings announcement. This is significantly higher than what&#39;s been typical over the past three years.
The increased volatility expectation highlights investors&#39; strong focus on Nvidia. The company has driven about 25% of the S&amp;P 500&#39;s gains this year, underscoring its impact on the broader market.
The anticipated earnings per share of $0.57 will be announced after market close this Wednesday, potentially driving expected fluctuations.
Nvidia&rsquo;s recent market performance adds complexity to the story. The stock has jumped 40% from this month&rsquo;s lows, boosting investor confidence. This rebound is part of a larger upward trend, with a 157% gain year-to-date, including a 9% increase in August.
Historically, Nvidia has shown strong recovery ability, bouncing back from sharp declines, as seen in the recent rally. This resilience is fueling the current bullish momentum, putting the stock close to previous record highs if it gains 10%.
However, navigating the stock market, especially with high-stakes earnings reports, requires nuance. A positive earnings surprise doesn&#39;t automatically lead to a stock price increase, as broader market dynamics and investor sentiment can separate financial results from stock performance.
<img alt="2024-08-28_15-26-20.jpg" src="https://www.benzinga.com/files/u517520/2024-08-28_15-26-20.jpg" style="height:308px; width:624px" />
This unpredictability makes the upcoming earnings report crucial. Adding complexity is Nvidia&#39;s stock movement within a significant range of $90 to $140.
Signs of bullish momentum in this zone suggest the possibility of a breakout. If the stock surpasses the $140 mark, it could quickly target the next resistance level at $150, paving the way for further gains.
After the closing bell on Wednesday, August 27, the stock closed at $128.30, trading down by 1.52%.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Nvidia's Next Earnings Report Could Swing Its Market Cap By $300 Billion And Increase The S&P 500 Gains

Wrapped Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WBTC</a>) price has decreased 4.21% over the past 24 hours to $59,121.00. This is contrary to the coins performance over the past week where it has experienced an up-trend of 1.0%, moving from $59,293.16 to its current price.
The chart below compares the price movement and volatility for Wrapped Bitcoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1724857427_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 8.0% over the past week while the circulating supply of the coin has risen 0.19%. This brings the circulating supply to 153 thousand, which makes up an estimated 100.0% of its max supply of 153 thousand. According to our data, the current market cap ranking for WBTC is #15 at $9.07 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1724857427_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$WBTC

Wrapped Bitcoin Decreases More Than 4% Within 24 hours

Disclosed on August 27, ROBERT STEPHENSON, Chief Financial Officer at Omega Healthcare Invts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: STEPHENSON's decision to sell 30,000 shares of Omega Healthcare Invts was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000888491/000141588924022291//Archives/edgar/data/888491/000141588924022291/0001415889-24-022291-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $1,163,520.
Omega Healthcare Invts's shares are actively trading at $39.45, experiencing a up of 0.46% during Wednesday's morning session.
<h3>All You Need to Know About Omega Healthcare Invts</h3>
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
<h3>Omega Healthcare Invts: A Financial Overview</h3>
Revenue Growth: Over the 3 months period, Omega Healthcare Invts showcased positive performance, achieving a revenue growth rate of 1.02% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Real Estate sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 98.52%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Omega Healthcare Invts's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 0.46.
</li>
</ul>
Debt Management: Omega Healthcare Invts's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.26.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 29.75 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 10.36 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 16.67 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000888491">Check Out The Full List Of Omega Healthcare Invts's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Transaction: ROBERT STEPHENSON Sells $1.16M Worth Of Omega Healthcare Invts Shares

A substantial insider sell was reported on August 27, by Megan Clarken, Chief Executive Officer at Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>), based on the recent SEC filing.
What Happened: Clarken's decision to sell 9,283 shares of Criteo was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001576427/000157642724000107//Archives/edgar/data/1576427/000157642724000107/0001576427-24-000107-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $456,445.
At Wednesday morning, Criteo shares are down by 0.42%, trading at $47.29.
<h3>All You Need to Know About Criteo</h3>
Headquartered in Paris, Criteo is one of the leading ad-tech companies in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.
<h3>Criteo: Delving into Financials</h3>
Positive Revenue Trend: Examining Criteo's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.51% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Communication Services sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 49.4%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Criteo's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 0.49.
</li>
</ul>
Debt Management: Criteo's debt-to-equity ratio is below the industry average. With a ratio of 0.1, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 27.61 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 1.5 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 11.07, Criteo could be considered undervalued.
</li>
</ul>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>A Closer Look at Important Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001576427">Check Out The Full List Of Criteo's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Get Our Top Trade Ideas Delivered Daily - 65% Off Now'

Comments

NEOS ETF Trust Kurv Yield Premium Strategy Tesla (TSLA) ETF

News

Latest news for NEOS ETF Trust Kurv Yield Premium Strategy Tesla (TSLA) ETF (BATS:TSLP)